Quarterly report · Q2
2931.TEDINET S100OYUS
Period2022-01-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks13 of 14 passed
Key figures · 45
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥21.6bn | 2022-01-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥34.4bn | 2020-10-01 → 2021-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.7bn | 2020-10-01 → 2021-03-31 | Cons. | Net sales |
| Operating income | −¥1.4bn | 2022-01-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | −¥511m | 2020-10-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | −¥597m | 2022-01-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | −¥6.4bn | 2020-10-01 → 2021-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥130m | 2020-10-01 → 2021-03-31 | Cons. | Ordinary income |
| Profit before tax | −¥595m | 2022-01-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥117m | 2020-10-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥465m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥5.0bn | 2020-10-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥196m | 2020-10-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥462m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | −¥194m | 2020-10-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥58.6bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥61.0bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥21.7bn | at 2021-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥38.8bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥40.4bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥19.9bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥20.6bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥11.1bn | at 2021-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥9.5bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.9bn | at 2021-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥9.3bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.8bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.2bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.1bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.4bn | 2020-10-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥362m | 2020-10-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥531m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥10.3bn | 2020-10-01 → 2021-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥5.9bn | 2020-10-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.1bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥12.1bn | 2020-10-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.1bn | 2020-10-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-4.18 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.54 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-49.07 | 2020-10-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.1 | 2020-10-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1.76 | 2021-01-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 33.1% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.0% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.0% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥810m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥63m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥63m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥376m |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥20.2bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥20.2bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥122m |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥113m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-01-01 → 2022-06-30 | ¥21.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-01-01 → 2022-06-30 | ¥21.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-01-01 → 2022-06-30 | −¥611m |
| Reconciling Itemsreconciling | segment profit | 2020-10-01 → 2021-03-31 | −¥697m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue | 2020-10-01 → 2021-03-31 | ¥5m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue external | 2020-10-01 → 2021-03-31 | ¥5m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | segment profit | 2020-10-01 → 2021-03-31 | −¥295m |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue | 2020-10-01 → 2021-03-31 | ¥7.4bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue external | 2020-10-01 → 2021-03-31 | ¥7.4bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | segment profit | 2020-10-01 → 2021-03-31 | ¥624m |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue | 2020-10-01 → 2021-03-31 | ¥288m |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue external | 2020-10-01 → 2021-03-31 | ¥288m |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | segment profit | 2020-10-01 → 2021-03-31 | −¥143m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-10-01 → 2021-03-31 | ¥7.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-10-01 → 2021-03-31 | ¥7.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-10-01 → 2021-03-31 | ¥185m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 595
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任監査法人トーマツ | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)早稲田 宏 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)萬 政広 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 7737000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 21584000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 34420000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | -130000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | -597000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | -6354000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | -196000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | -465000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | -5038000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | -199000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | -481000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | -5853000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 11067000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 19861000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 20588000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 21669000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 58648000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 61007000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | -2.10 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | -4.18 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | -49.07 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.510 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.331 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.330 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 362000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 1059000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 1378000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -5938000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -531000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -10338000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | 3123000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -1085000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 12062000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 4182000000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 9271000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 9820000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 1.76 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | -4.54 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 111308860 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 113032960 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 111308860 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 113032960 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | partial |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |